NFA
ACAD icon

Nationwide Fund Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Nationwide Fund Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38,350
Closed -$1.45M – 22
2017
Q3 		$1.45M Buy
38,350
+11,410
+42% +$371K 0.01% 1599
2017
Q2 		$751K Buy
26,940
+14,600
+118% +$435K ﹤0.01% 1952
2017
Q1 		$424K Buy
+12,340
New +$436K ﹤0.01% 2241
2016
Q4 		– Sell
-36,330
Closed -$1.16M – 3192
2016
Q3 		$1.16M Buy
36,330
+9,010
+33% +$305K ﹤0.01% 1690
2016
Q2 		$887K Sell
27,320
-27,227
-50% -$911K ﹤0.01% 1801
2016
Q1 		$1.55M Sell
54,547
-12,096
-18% -$264K 0.01% 1477
2015
Q4 		$2.38M Buy
66,643
+15,282
+30% +$538K 0.01% 1285
2015
Q3 		$1.7M Sell
51,361
-281
-0.5% -$11.7K 0.01% 1455
2015
Q2 		$2.16M Sell
51,642
-70,916
-58% -$2.74M 0.01% 1389
2015
Q1 		$3.99M Buy
122,558
+62,669
+105% +$2.15M 0.02% 1093
2014
Q4 		$1.9M Sell
59,889
-746
-1% -$21.2K 0.01% 1442
2014
Q3 		$1.5M Buy
60,635
+14
+0% +$327 0.01% 1599
2014
Q2 		$1.37M Buy
+60,621
New +$1.27M 0.01% 1697
2014
Q1 		– Sell
-54,212
Closed -$1.35M – 3052
2013
Q4 		$1.35M Sell
54,212
-1,533
-3% -$36.2K 0.01% 1699
2013
Q3 		$1.53M Buy
55,745
+33,211
+147% +$694K 0.01% 1596
2013
Q2 		$409K Buy
+22,534
New +$310K ﹤0.01% 2105

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nationwide Fund Advisors's ACAD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Acadia Pharmaceuticals (ACAD) in Q4 2017, closing a stake of 38,350 shares — an estimated $1.45M sold.

Nationwide Fund Advisors first reported a position in ACAD in Q2 2013 and held it in 16 quarters. The position peaked at $3.99M in Q1 2015. 210 funds tracked by Wall St. Rank hold ACAD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Acadia Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 38,350 Acadia Pharmaceuticals shares in Q4 2017, an estimated $1.45M.
  • Nationwide Fund Advisors first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's Acadia Pharmaceuticals position peaked at $3.99M in Q1 2015.
  • 210 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.